These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid]. BERNARD J; MATHE G; WEIL M Sang; 1957; 28(1):80-2. PubMed ID: 13432604 [No Abstract] [Full Text] [Related]
4. [Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases]. BERNARD J; MATHE G; WEIL M Rev Fr Etud Clin Biol; 1956 Dec; 1(10):1121-32. PubMed ID: 13408766 [No Abstract] [Full Text] [Related]
5. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma]. NARDI FL Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986 [No Abstract] [Full Text] [Related]
6. Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases. HOCHMAN A; ICKOWICZ M Br J Radiol; 1954 Aug; 27(320):467-9. PubMed ID: 13182191 [No Abstract] [Full Text] [Related]
7. [Experimental and clinical studies on the toxic and therapeutic effect of both nitrogen mustard compounds, trichlortriethylamine and dichloro-diethylamine]. GOHR H; GORGES T; BOLDER H Z Gesamte Inn Med; 1953 Aug; 8(15):692-6. PubMed ID: 13170111 [No Abstract] [Full Text] [Related]
8. Hyperuricemia with uric acid nephropathy following nitrogen mustard therapy of lymphosarcoma; report of a case. WINKLER JW Med Ann Dist Columbia; 1959 Feb; 28(2):77-8 passim. PubMed ID: 13643089 [No Abstract] [Full Text] [Related]
9. The histopathological changes induced by the nitrogen mustards in the lymphomas: a brief review of the literature. CAPUTI S R I Med J; 1959 Apr; 42(4):242-5 passim. PubMed ID: 13646447 [No Abstract] [Full Text] [Related]
10. [Treatment of lymphosarcoma]. LAMBERS K Arztl Wochensch; 1958 Aug; 13(30-31):692-4. PubMed ID: 13571057 [No Abstract] [Full Text] [Related]
11. [Nitrogen mustard and Hodgkin's disease; case report]. PERIERA JR Port Med; 1953 Nov; 37(11):645-58. PubMed ID: 13120577 [No Abstract] [Full Text] [Related]
12. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms]. INGRASSIA G; VASILE B Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882 [No Abstract] [Full Text] [Related]
13. [Treatment of Hodgkin's disease with nitrogen mustards]. CHEVALLIER P; BILSKI-PASQUIER G; CHRISTOL D; BOIRON M Sem Hop; 1954 Feb; 30(13):774-7. PubMed ID: 13146192 [No Abstract] [Full Text] [Related]
14. [Observations on three years of clinical experience with nitrogen mustard]. CUCINOTTA U G Ital Chemioter; 1954; 1(1):175-7. PubMed ID: 13191617 [No Abstract] [Full Text] [Related]
15. [Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions]. INTROZZI P; MARINONE G Haematologica; 1953; 37(11):1195-1274. PubMed ID: 13151517 [No Abstract] [Full Text] [Related]
16. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative]. ZULIK R Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105 [No Abstract] [Full Text] [Related]
17. [The hydrochloride of 2,2'-dichloro-N-methyldiethylamine N-oxide in the therapy of malignant blood diseases]. CONSOLI G G Ital Chemioter; 1954; 1(1):154-6. PubMed ID: 13191611 [No Abstract] [Full Text] [Related]
18. [Therapy of Hodgkin's disease (lymphogranulomatosis)]. MOSCHIDIS C; KIOSOGLOU K; MAOUNI F Ann Paediatr; 1958 Jun; 190(6):333-41. PubMed ID: 13545663 [No Abstract] [Full Text] [Related]